{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T23:00:13Z","timestamp":1785106813879,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53817-5","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:06:05Z","timestamp":1779375965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-drug interactions with direct oral anticoagulants in Belgian primary care patients with non-valvular atrial fibrillation"],"prefix":"10.1038","volume":"16","author":[{"given":"Victoria A.","family":"Fuchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lor\u00e8ne","family":"Zerah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Henrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"53817_CR1","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder, I. C. et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur. Heart J. 45, 3314\u20133414 (2024).","journal-title":"Eur. Heart J."},{"key":"53817_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1747493019897870","volume":"16","author":"G Lippi","year":"2020","unstructured":"Lippi, G., Sanchis-Gomar, F. & Cervellin, G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int. J. Stroke. 16, 217\u2013221 (2020).","journal-title":"Int. J. Stroke"},{"key":"53817_CR3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S0140-6736(11)61514-6","volume":"379","author":"GY Lip","year":"2012","unstructured":"Lip, G. Y., Tse, H. F. & Lane, D. A. Atrial fibrillation. Lancet 379, 648\u2013661 (2012).","journal-title":"Lancet"},{"key":"53817_CR4","doi-asserted-by":"publisher","first-page":"e13070","DOI":"10.1111\/ijcp.13070","volume":"72","author":"H Zulkifly","year":"2018","unstructured":"Zulkifly, H., Lip, G. Y. H. & Lane, D. A. Epidemiology of atrial fibrillation. Int. J. Clin. Pract. 72, e13070 (2018).","journal-title":"Int. J. Clin. Pract."},{"key":"53817_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.thromres.2020.08.016","volume":"194","author":"A Li","year":"2020","unstructured":"Li, A., Li, M. K., Crowther, M. & Vazquez, S. R. Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review. Thromb. Res. 194, 240\u2013245 (2020).","journal-title":"Thromb. Res."},{"key":"53817_CR6","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel, J. et al. 2021 European Heart Rhythm Association Practical guide on the use of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation. EP Europace. 23, 1612\u20131676 (2021).","journal-title":"EP Europace"},{"key":"53817_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10557-023-07521-5","volume":"39","author":"M Grymonprez","year":"2023","unstructured":"Grymonprez, M. et al. Pharmacodynamic drug-drug interactions and bleeding outcomes in patients with atrial fibrillation using non-vitamin k antagonist oral anticoagulants: a nationwide cohort study. Cardiovasc. Drugs Ther. 39, 133\u2013143 (2023).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"53817_CR8","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1111\/bcp.15265","volume":"88","author":"M Grymonprez","year":"2022","unstructured":"Grymonprez, M. et al. Impact of P-glycoprotein and\/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A meta-analysis. Br. J. Clin. Pharmacol. 88, 3039\u20133051 (2022).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"53817_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.thromres.2024.05.006","volume":"238","author":"A Capiau","year":"2024","unstructured":"Capiau, A. et al. Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants: an intervention study in community pharmacies. Thromb. Res. 238, 223\u2013231 (2024).","journal-title":"Thromb. Res."},{"key":"53817_CR10","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.clinthera.2025.04.003","volume":"47","author":"M Giner-Soriano","year":"2025","unstructured":"Giner-Soriano, M. et al. Association between anticoagulants and interacting drugs and risk of major bleeding in nonvalvular atrial fibrillation: case-control study in SIDIAP, Catalonia, Spain. Clin. Ther. 47, 484\u2013491 (2025).","journal-title":"Clin. Ther."},{"key":"53817_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/17425255.2020.1700952","volume":"16","author":"E Spina","year":"2020","unstructured":"Spina, E., Barbieri, M. A., Cicala, G., Bruno, A. & de Leon, J. Clinically relevant drug interactions between newer antidepressants and oral anticoagulants. Expert Opin. Drug Metab. Toxicol. 16, 31\u201344 (2020).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"53817_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.amjcard.2021.09.025","volume":"162","author":"D Sanborn","year":"2022","unstructured":"Sanborn, D. et al. Outcomes of direct oral anticoagulants co-prescribed with common interacting medications. Am. J. Cardiol. 162, 80\u201385 (2022).","journal-title":"Am. J. Cardiol."},{"key":"53817_CR13","doi-asserted-by":"publisher","first-page":"100137","DOI":"10.1016\/j.rpth.2023.100137","volume":"7","author":"M Candeloro","year":"2023","unstructured":"Candeloro, M., Carlin, S., Shapiro, M. J. & Douketis, J. D. Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review. Res. Pract. Thromb. Haemost. 7, 100137 (2023).","journal-title":"Res. Pract. Thromb. Haemost"},{"key":"53817_CR14","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1111\/bcp.15710","volume":"89","author":"D Li","year":"2023","unstructured":"Li, D. et al. Evidence of potential pro-haemorrhagic drug interactions between CYP3A4 inhibitors and direct oral anticoagulants: Analysis of the FAERS database. Br. J. Clin. Pharmacol. 89, 2423\u20132429 (2023).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"53817_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.jacc.2019.12.068","volume":"75","author":"BS Wiggins","year":"2020","unstructured":"Wiggins, B. S., Dixon, D. L., Neyens, R. R., Page, R. L. & Gluckman, T. J. Select drug-drug interactions with direct oral anticoagulants: JACC review topic of the week. J. Am. Coll. Cardiol. 75, 1341\u20131350 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"53817_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00228-020-03015-7","volume":"77","author":"J Holm","year":"2021","unstructured":"Holm, J., Mannheimer, B., Malmstr\u00f6m, R. E., Eliasson, E. & Lindh, J. D. Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants-a Swedish, register-based cohort study in atrial fibrillation outpatients. Eur. J. Clin. Pharmacol. 77, 409\u2013419 (2021).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"53817_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/ehjcvp\/pvad070","volume":"9","author":"M Grymonprez","year":"2023","unstructured":"Grymonprez, M. et al. Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study. Eur. Heart J. Cardiovasc. Pharmacother. 9, 722\u2013730 (2023).","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother"},{"key":"53817_CR18","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.amjmed.2021.06.003","volume":"134","author":"AL Sennesael","year":"2021","unstructured":"Sennesael, A. L. et al. The impact of strong inducers on direct oral anticoagulant levels. Am. J. Med. 134, 1295\u20131299 (2021).","journal-title":"Am. J. Med."},{"key":"53817_CR19","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1111\/bcp.14071","volume":"85","author":"L Ib\u00e1\u00f1ez","year":"2019","unstructured":"Ib\u00e1\u00f1ez, L. et al. Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008\u20132015): A cross-national drug utilization study. Br. J. Clin. Pharmacol. 85, 2524\u20132539 (2019).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"53817_CR20","doi-asserted-by":"publisher","first-page":"e015089","DOI":"10.1161\/JAHA.119.015089","volume":"9","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Polypharmacy, adverse outcomes, and treatment effectiveness in patients\u2009\u2265\u200975 with atrial fibrillation. J. Am. Heart Assoc. 9, e015089 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"53817_CR21","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370, 1453\u20131457 (2007).","journal-title":"Lancet"},{"key":"53817_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pds.1335","volume":"16","author":"JD Lewis","year":"2007","unstructured":"Lewis, J. D., Schinnar, R., Bilker, W. B., Wang, X. & Strom, B. L. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 16, 393\u2013401 (2007).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"53817_CR23","unstructured":"Cegedim Health Data. THIN: The Health Improvement Network. https:\/\/www.cegedim-health-data.com\/cegedim-health-data\/thin-the-health-improvement-network\/ (2023)"},{"key":"53817_CR24","unstructured":"Association Pharmaeucitque Belge. Phil. http:\/\/www.apb.be\/fr-BE\/Article\/phil~221FR (2023)"},{"key":"53817_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks, G. et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 42, 373\u2013498 (2021).","journal-title":"Heart J."},{"key":"53817_CR26","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00228-020-02952-7","volume":"76","author":"C Souty","year":"2020","unstructured":"Souty, C. et al. Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions. Eur. J. Clin. Pharmacol. 76, 1675\u20131682 (2020).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"53817_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijcard.2020.11.062","volume":"328","author":"A Capiau","year":"2021","unstructured":"Capiau, A. et al. Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA Practical Guide. Int. J. Cardiol. 328, 97\u2013103 (2021).","journal-title":"Int. J. Cardiol."},{"key":"53817_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11096-022-01511-7","volume":"45","author":"A Capiau","year":"2023","unstructured":"Capiau, A. et al. Drug-drug interactions with direct oral anticoagulants: development of a consensus list for ambulatory care. Int. J. Clin. Pharm. 45, 364\u2013374 (2023).","journal-title":"Int. J. Clin. Pharm."},{"key":"53817_CR29","doi-asserted-by":"publisher","first-page":"e85071","DOI":"10.1371\/journal.pone.0085071","volume":"8","author":"SP Slight","year":"2013","unstructured":"Slight, S. P. et al. Are we heeding the warning signs? Examining providers\u2019 overrides of computerized drug-drug interaction alerts in primary care. PLOS ONE. 8, e85071 (2013).","journal-title":"PLOS ONE"},{"key":"53817_CR30","doi-asserted-by":"crossref","unstructured":"Coumau, C. et al. Drug-drug interactions with oral anticoagulants: information consistency assessment of three commonly used online drug interactions databases in Switzerland. Front Pharmacol 15, (2024).","DOI":"10.3389\/fphar.2024.1332147"},{"key":"53817_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.thromres.2019.12.023","volume":"187","author":"AL Sennesael","year":"2020","unstructured":"Sennesael, A. L., Krug, B., Sneyers, B. & Spinewine, A. Do computerized clinical decision support systems improve the prescribing of oral anticoagulants? A systematic review. Thromb. Res. 187, 79\u201387 (2020).","journal-title":"Thromb. Res."},{"key":"53817_CR32","doi-asserted-by":"publisher","first-page":"e12803","DOI":"10.1002\/rth2.12803","volume":"6","author":"FJ Seagull","year":"2022","unstructured":"Seagull, F. J. et al. Implementing evidence-based anticoagulant prescribing: User-centered design findings and recommendations. Res. Pract. Thromb. Haemost. 6, e12803 (2022).","journal-title":"Res. Pract. Thromb. Haemost"},{"key":"53817_CR33","doi-asserted-by":"publisher","first-page":"791285","DOI":"10.3389\/fnagi.2022.791285","volume":"14","author":"KH Chang","year":"2022","unstructured":"Chang, K. H. et al. Major bleeding risk in patients with non-valvular atrial fibrillation concurrently taking direct oral anticoagulants and antidepressants. Front. Aging Neurosci. 14, 791285 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"53817_CR34","doi-asserted-by":"publisher","first-page":"e243208","DOI":"10.1001\/jamanetworkopen.2024.3208","volume":"7","author":"AA Rahman","year":"2024","unstructured":"Rahman, A. A. et al. Concomitant use of selective serotonin reuptake inhibitors with oral anticoagulants and risk of major bleeding. JAMA Netw. Open. 7, e243208 (2024).","journal-title":"JAMA Netw. Open."},{"key":"53817_CR35","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/bcp.14227","volume":"86","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study. Br. J. Clin. Pharmacol. 86, 1150\u20131164 (2020).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"53817_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/cpt.1603","volume":"107","author":"JJ Komen","year":"2020","unstructured":"Komen, J. J. et al. Concomitant anticoagulant and antidepressant therapy in atrial fibrillation patients and risk of stroke and bleeding. Clin. Pharmacol. Ther. 107, 287\u2013294 (2020).","journal-title":"Clin. Pharmacol. Ther."},{"key":"53817_CR37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.rpsm.2022.12.001","volume":"18","author":"G Anmella","year":"2025","unstructured":"Anmella, G. et al. Antidepressants overuse in primary care: Prescription trends between 2010 and 2019 in Catalonia. Span. J. Psychiatry Ment Health. 18, 174\u2013181 (2025).","journal-title":"Span. J. Psychiatry Ment Health"},{"key":"53817_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/17512433.2021.1908124","volume":"14","author":"C St\u00f6llberger","year":"2021","unstructured":"St\u00f6llberger, C. & Finsterer, J. Update on drug interactions with non-vitamin-K-antagonist oral anticoagulants for stroke prevention in elderly patients. Expert Rev. Clin. Pharmacol. 14, 569\u2013581 (2021).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"53817_CR39","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3349\/ymj.2020.61.9.741","volume":"61","author":"MT Lee","year":"2020","unstructured":"Lee, M. T. et al. Concomitant use of NSAIDs or SSRIs with NOACs requires monitoring for bleeding. Yonsei Med. J. 61, 741\u2013749 (2020).","journal-title":"Yonsei Med. J."},{"key":"53817_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/ehjcvp\/pvz069","volume":"6","author":"AMS Olsen","year":"2020","unstructured":"Olsen, A. M. S. et al. Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study. Eur. Heart J. Cardiovasc. Pharmacother. 6, 292\u2013300 (2020).","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother"},{"key":"53817_CR41","doi-asserted-by":"publisher","first-page":"22403","DOI":"10.1038\/s41598-021-01786-2","volume":"11","author":"JY Lee","year":"2021","unstructured":"Lee, J. Y. et al. Drug-drug interactions in atrial fibrillation patients receiving direct oral anticoagulants. Sci. Rep. 11, 22403 (2021).","journal-title":"Sci. Rep."},{"key":"53817_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/eurheartj\/ehae736","volume":"46","author":"SR Petersen","year":"2025","unstructured":"Petersen, S. R., Bonnesen, K., Grove, E. L., Pedersen, L. & Schmidt, M. Bleeding risk using non-steroidal anti-inflammatory drugs with anticoagulants after venous thromboembolism: a nationwide Danish study. Eur. Heart J. 46, 58\u201368 (2025).","journal-title":"Eur. Heart J."},{"key":"53817_CR43","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"American Geriatrics Society","year":"2023","unstructured":"American Geriatrics Society. 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 71, 2052\u20132081 (2023).","journal-title":"J. Am. Geriatr. Soc."},{"key":"53817_CR44","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s11239-020-02367-2","volume":"52","author":"M Romoli","year":"2021","unstructured":"Romoli, M., Marchetti, G., Bernardini, F. & Urbinati, S. Switching between direct oral anticoagulants: a systematic review and meta-analysis. J. Thromb. Thrombolysis. 52, 560\u2013566 (2021).","journal-title":"J. Thromb. Thrombolysis"},{"key":"53817_CR45","doi-asserted-by":"publisher","first-page":"e071907","DOI":"10.1136\/bmjopen-2023-071907","volume":"13","author":"AR Adelakun","year":"2023","unstructured":"Adelakun, A. R., Turgeon, R. D., De Vera, M. A., McGrail, K. & Loewen, P. S. Oral anticoagulant switching in patients with atrial fibrillation: a scoping review. BMJ open. 13, e071907 (2023).","journal-title":"BMJ open."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53817-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53817-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53817-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:42:59Z","timestamp":1785105779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53817-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53817"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53817-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23253"}}